TY - JOUR
T1 - Placental pathology is necessary to understand common pregnancy complications and achieve an improved taxonomy of obstetrical disease
AU - Redline, Raymond W.
AU - Roberts, Drucilla J.
AU - Parast, Mana M.
AU - Ernst, Linda M.
AU - Morgan, Terry K.
AU - Greene, Michael F.
AU - Gyamfi-Bannerman, Cynthia
AU - Louis, Judette M.
AU - Maltepe, Emin
AU - Mestan, Karen K.
AU - Romero, Roberto
AU - Stone, Joanne
N1 - Funding Information:
This article was supported, in part, by the Perinatology Research Branch , Division of Obstetrics and Maternal-Fetal Medicine , Division of Intramural Research , Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Human Services (NICHD/NIH/DHHS) and, in part, with federal funds from the NICHD/NIH/DHHS under contract number HHSN275201300006C.
Funding Information:
This article was supported, in part, by the Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Human Services (NICHD/NIH/DHHS) and, in part, with federal funds from the NICHD/NIH/DHHS under contract number HHSN275201300006C.
Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2023/2
Y1 - 2023/2
N2 - The importance of a fully functioning placenta for a good pregnancy outcome is unquestioned. Loss of function can lead to pregnancy complications and is often detected by a thorough placental pathologic examination. Placental pathology has advanced the science and practice of obstetrics and neonatal-perinatal medicine by classifying diseases according to underlying biology and specific patterns of injury. Many past obstacles have limited the incorporation of placental findings into both clinical studies and day-to-day practice. Limitations have included variability in the nomenclature used to describe placental lesions, a shortage of perinatal pathologists fully competent to analyze placental specimens, and a troubling lack of understanding of placental diagnoses by clinicians. However, the potential use of placental pathology for phenotypic classification, improved understanding of the biology of adverse pregnancy outcomes, the development of treatment and prevention, and patient counseling has never been greater. This review, written partly in response to a recent critique published in a major obstetrics-gynecology journal, reexamines the role of placental pathology by reviewing current concepts of biology; explaining the most recent terminology; emphasizing the usefulness of specific diagnoses for obstetrician-gynecologists, neonatologists, and patients; previewing upcoming changes in recommendations for placental submission; and suggesting future improvements. These improvements should include further consideration of overall healthcare costs, cost-effectiveness, the clinical value added of placental assessment, improvements in placental pathology education and practice, and leveraging of placental pathology to identify new biomarkers of disease and evaluate novel therapies tailored to specific clinicopathologic phenotypes of both women and infants.
AB - The importance of a fully functioning placenta for a good pregnancy outcome is unquestioned. Loss of function can lead to pregnancy complications and is often detected by a thorough placental pathologic examination. Placental pathology has advanced the science and practice of obstetrics and neonatal-perinatal medicine by classifying diseases according to underlying biology and specific patterns of injury. Many past obstacles have limited the incorporation of placental findings into both clinical studies and day-to-day practice. Limitations have included variability in the nomenclature used to describe placental lesions, a shortage of perinatal pathologists fully competent to analyze placental specimens, and a troubling lack of understanding of placental diagnoses by clinicians. However, the potential use of placental pathology for phenotypic classification, improved understanding of the biology of adverse pregnancy outcomes, the development of treatment and prevention, and patient counseling has never been greater. This review, written partly in response to a recent critique published in a major obstetrics-gynecology journal, reexamines the role of placental pathology by reviewing current concepts of biology; explaining the most recent terminology; emphasizing the usefulness of specific diagnoses for obstetrician-gynecologists, neonatologists, and patients; previewing upcoming changes in recommendations for placental submission; and suggesting future improvements. These improvements should include further consideration of overall healthcare costs, cost-effectiveness, the clinical value added of placental assessment, improvements in placental pathology education and practice, and leveraging of placental pathology to identify new biomarkers of disease and evaluate novel therapies tailored to specific clinicopathologic phenotypes of both women and infants.
KW - acute chorioamnionitis
KW - biomarker
KW - chronic chorioamnionitis
KW - chronic histiocytic intervillositis
KW - cost-effectiveness
KW - diagnosis
KW - economic analysis
KW - fetal death
KW - fetal growth restriction
KW - fetal vascular malperfusion
KW - funisitis
KW - immunohistochemistry
KW - infection
KW - inflammation
KW - massive perivillous fibrin
KW - maternal vascular malperfusion
KW - placental abruption
KW - preeclampsia
KW - preterm birth
KW - recurrent pregnancy loss
KW - small for gestational age
KW - stillbirth
KW - thrombosis
KW - villitis of unknown etiology
UR - http://www.scopus.com/inward/record.url?scp=85143267500&partnerID=8YFLogxK
U2 - 10.1016/j.ajog.2022.08.010
DO - 10.1016/j.ajog.2022.08.010
M3 - Article
C2 - 35973475
AN - SCOPUS:85143267500
SN - 0002-9378
VL - 228
SP - 187
EP - 202
JO - American Journal of Obstetrics and Gynecology
JF - American Journal of Obstetrics and Gynecology
IS - 2
ER -